10 Min
In Sponsored Education
Bookmark
INTRODUCING
Erectile dysfunction (ED), which may be referred to as erection problems (EPs) by customers, refers to the inability to achieve and/or maintain an erection for satisfactory sexual performance.1,2
ED is very common, although the prevalence may be underestimated due to under-reporting to healthcare professionals.2
AVARANTE® (TADALAFIL 10MG) IS A NEW* PHARMACY-ONLY MEDICINE LICENSED FOR THE TREATMENT OF ED
AVARANTE joins VIAGRA CONNECT (sildenafil 50mg) to expand the Viatris range of P-medicines for ED.
Although both products' active ingredients belong to the same drug class, they have slightly different profiles.3 Understanding each product’s unique properties will enable you to tailor your treatment recommendations according to your customer’s individual needs.
*New from the makers of VIAGRA CONNECT
After completing this module, you will:
Understand the various underlying causes of ED and which lifestyle changes may help to reduce the risk of developing it
Know what AVARANTE is, when you can supply it and what advice to share with customers
Be able to support your customers to choose between the pharmacological treatment options for ED through effective customer consultations.
This training is for pharmacists, but it can also be used by pharmacy team members to understand more about this product.
This training module is not intended to replace the AVARANTE Risk Minimisation Materials (RMMs).
You can access these RMMs at https://www.medicines.org.uk/emc/product/100210/rmms#about-medicine.
Pharmacy Guide for AVARANTE 10mg film-coated tablets (tadalafil)
AVARANTE 10mg film-coated tablets (tadalafil) Pharmacist Checklist Quick Guide
AVARANTE 10mg film-coated tablets (tadalafil) Repeat Purchase/Referral Card
UK-AVT-2024-00060
April 2025
Content developed by Viatris working with CIG Healthcare Partnership.
© 2025 CIG Healthcare Partnership